The text discusses various studies related to rectal and colon cancer, including the incidence and patterns of late recurrences, familial deficiency of dihydropyrimidine dehydrogenase, prognostic biomarkers, adjuvant treatments, and the impact of delaying chemotherapy on survival. It also highlights the importance of CDX2 protein expression as a prognostic biomarker in colon cancer.